Group 1 - The core point of the article is that Juzhi Biotechnology has been actively repurchasing its shares on the Hong Kong Stock Exchange, indicating a strategy to support its stock price and enhance shareholder value [2] - On December 19, the company repurchased 400,000 shares at a price range of HKD 34.540 to HKD 35.520, with a total repurchase amount of HKD 14.0536 million [2] - Since December 9, the company has conducted share repurchases for nine consecutive days, totaling 3.6 million shares and a cumulative repurchase amount of HKD 127 million [2] Group 2 - The stock price on the day of the repurchase closed at HKD 35.480, reflecting a 2.60% increase, with a total trading volume of HKD 277 million [2] - The detailed repurchase data shows consistent repurchase activity, with each day involving the repurchase of 40,000 shares at varying prices, indicating a structured approach to share buybacks [2] - The cumulative stock price decline during the repurchase period was 2.53%, suggesting that the company's buyback strategy may be aimed at countering this downward trend [2]
巨子生物(02367.HK)连续9日回购，累计回购360.00万股